What is the diagnostic approach for hemolytic anemia?

Diagnostic Approach to Hemolytic Anemia

Begin by confirming hemolysis with laboratory markers: elevated reticulocyte count, increased lactate dehydrogenase (LDH), decreased haptoglobin, and elevated unconjugated bilirubin. 1, 2, 3

Initial Laboratory Confirmation

The diagnosis of hemolytic anemia requires documentation of:

• Increased reticulocyte count (indicating bone marrow compensation)
• Elevated LDH (released from destroyed red cells)
• Decreased or absent haptoglobin (consumed by binding free hemoglobin)
• Elevated unconjugated (indirect) bilirubin (from heme catabolism)

These four markers together establish that hemolysis is occurring 1, 3.

Critical First Branching Point: Direct Antiglobulin Test (DAT)

After confirming hemolysis, immediately perform a Direct Antiglobulin Test (DAT/Coombs test) to separate immune from non-immune causes 2, 3, 4. This single test determines your entire diagnostic pathway:

DAT-Positive (Immune-Mediated)

Indicates antibodies and/or complement on red cell surface:

• Warm autoimmune hemolytic anemia (wAIHA) - IgG antibodies, most common (60-70% of immune cases) 4, 5
• Cold agglutinin disease (CAD) - IgM antibodies with complement activation (20-25% of cases) 4, 5
• Drug-induced hemolytic anemia 2, 3
• Delayed hemolytic transfusion reactions 2

DAT-Negative (Non-Immune)

Proceed to peripheral blood smear examination 1, 2, 3:

Peripheral Blood Smear Analysis

The red cell morphology on smear directs you to specific diagnostic categories 1, 3:

Abnormal RBC Morphology Patterns:

• Spherocytes → hereditary spherocytosis (membrane disorder)
• Sickle cells → sickle cell disease (hemoglobinopathy)
• Target cells → thalassemia or other hemoglobinopathies
• Schistocytes/fragmented cells → microangiopathic hemolytic anemia (thrombotic microangiopathy, mechanical trauma, DIC) 2, 3
• Bite cells, blister cells → oxidative damage (G6PD deficiency, drug exposure)
• Echinocytes (3-30%) with otherwise unremarkable morphology → consider enzyme deficiencies like pyruvate kinase deficiency 1

Near-Normal Morphology

When red cell morphology is normal or shows only nonspecific anisocytosis/poikilocytosis, suspect red cell enzyme deficiencies 1. This is a critical diagnostic clue often missed.

Systematic Exclusion Algorithm for Non-Immune Hemolysis

After DAT-negative result and smear review, systematically exclude:

1. Hemoglobinopathies

   • Hemoglobin electrophoresis or HPLC 6
   • Consider genetic testing if indicated

2. Membrane disorders

   • Osmotic fragility testing (though can be normal in some cases) 1
   • Eosin-5-maleimide (EMA) binding test for hereditary spherocytosis

3. Paroxysmal nocturnal hemoglobinuria (PNH)

   • Flow cytometry for CD55/CD59 deficiency 1

4. Red cell enzyme deficiencies

   • Pyruvate kinase (PK) enzyme activity assay - most common glycolytic enzymopathy 1
   • G6PD enzyme assay
   • Molecular/genetic testing (PKLR gene sequencing) 1

Special Diagnostic Considerations

When to Suspect Pyruvate Kinase Deficiency

Consider PK deficiency specifically in 1:

• Chronic hemolysis with normal or near-normal red cell morphology
• Transfusion-dependent anemia of unknown cause
• Neonates with unexplained severe hyperbilirubinemia
• Paradoxical increase in reticulocytes after splenectomy (highly suggestive)
• Positive family history
• Iron overload disproportionate to transfusion history

Important caveat: Reticulocytosis may be less pronounced than expected in non-splenectomized PK deficiency patients due to splenic sequestration of young PK-deficient cells 1.

Timing Considerations

• Avoid testing within 3 months of transfusion when possible, as donor cells interfere with enzyme assays and genetic studies 1
• Document transfusion history with all samples 1

Family Studies

Test parents and siblings when hereditary causes are suspected, particularly for enzyme deficiencies, to confirm heterozygous carrier states 1. This is standard practice in European reference centers and strengthens diagnostic certainty 1.

Advanced Diagnostic Tools

When conventional testing fails to identify the cause:

• Next-generation sequencing (NGS) panels for hereditary hemolytic anemias 7, 6, 8
• Testing for large PKLR gene deletions if PK deficiency suspected with incomplete genotype 1
• Automated blood cell analyzer parameters with artificial intelligence algorithms 7

Clinical Context Requirements

Always obtain 1:

• Complete clinical history including neonatal jaundice
• Family history of anemia, jaundice, splenectomy, or gallstones
• Transfusion history with dates
• Physical examination findings (splenomegaly, jaundice)

Pitfalls to Avoid

1. Do not assume CKD is the sole cause of anemia in kidney disease patients - hemolysis can coexist 9
2. Do not rely on osmotic fragility alone - it can be normal or abnormal in PK deficiency 1
3. Do not dismiss mild cases - compensated hemolysis without severe anemia still requires diagnosis 1
4. Do not skip the DAT - it is the single most important branching point 2, 3, 4
5. Do not overlook drug history - many medications cause hemolysis through various mechanisms 2, 3